RedPoint Oncology
Holden
About RedPoint Oncology
RedPoint Oncology is a targeted precision oncology company focused on developing next-generation antibody-drug conjugates (ADCs) to create best-in-class therapies for lethal solid tumors that currently have no cure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Grant (Apr 2025)
Industries & Categories
Biotechnology, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/redpoint-oncology-2242042 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.